Swati Tomar1, Christian A Graves1, Diego Altomare2, Sangeeta Kowli1, Susannah Kassler2, Natalie Sutkowski3, M Boyd Gillespie4, Kim E Creek2, Lucia Pirisi1. 1. Department of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina. 2. Department of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, South Carolina. 3. Department of Microbiology and Immunology, Medical University of South Carolina, Columbia, South Carolina. 4. Department of Otolaryngology and Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina.
Abstract
BACKGROUND: Disparities in prevalence, human papillomavirus (HPV) status, and mortality rates for head and neck cancer have been described between African American and European American patients. METHODS: We studied the HPV status and gene expression profiles in 56 oropharyngeal/oral cavity tumors and 9 normal tissue samples from European American and African American patients treated in South Carolina between 2010 and 2012. RESULTS: Overall, 59% of tumors were HPV DNA-positive, but only 48% of those expressed E7 mRNA (HPV-active). The prevalence of HPV-active tumors was 10% in African American patients and 39% in European American patients. Tumors positive for HPV DNA but negative for HPV mRNA exhibited gene expression profiles distinct from those of both HPV-active and HPV-negative cancers, suggesting that HPV DNA-positive/RNA-negative tumors may constitute a unique group. CONCLUSION: This study provides a direct assessment of differential expression patterns in HPV-related oropharyngeal cancer arising from African American and European American patients, for which there is a paucity of data.
BACKGROUND: Disparities in prevalence, human papillomavirus (HPV) status, and mortality rates for head and neck cancer have been described between African American and European American patients. METHODS: We studied the HPV status and gene expression profiles in 56 oropharyngeal/oral cavity tumors and 9 normal tissue samples from European American and African American patients treated in South Carolina between 2010 and 2012. RESULTS: Overall, 59% of tumors were HPV DNA-positive, but only 48% of those expressed E7 mRNA (HPV-active). The prevalence of HPV-active tumors was 10% in African American patients and 39% in European American patients. Tumors positive for HPV DNA but negative for HPV mRNA exhibited gene expression profiles distinct from those of both HPV-active and HPV-negative cancers, suggesting that HPV DNA-positive/RNA-negative tumors may constitute a unique group. CONCLUSION: This study provides a direct assessment of differential expression patterns in HPV-related oropharyngeal cancer arising from African American and European American patients, for which there is a paucity of data.
Authors: Andrew G Schache; Triantafilos Liloglou; Janet M Risk; Anastasia Filia; Terence M Jones; Jon Sheard; Julia A Woolgar; Timothy R Helliwell; Asterios Triantafyllou; Max Robinson; Philip Sloan; Colin Harvey-Woodworth; Daniel Sisson; Richard J Shaw Journal: Clin Cancer Res Date: 2011-10-01 Impact factor: 12.531
Authors: David D Wilson; Asal S Rahimi; Drew K Saylor; Edward B Stelow; Mark J Jameson; David C Shonka; James F Reibel; Paul A Levine; Paul W Read Journal: Arch Otolaryngol Head Neck Surg Date: 2012-06
Authors: Dan P Zandberg; Sandy Liu; Olga Goloubeva; Robert Ord; Scott E Strome; Mohan Suntharalingam; Rodney Taylor; Robert E Morales; Jeffrey S Wolf; Ann Zimrin; Joshua E Lubek; Lisa M Schumaker; Kevin J Cullen Journal: Head Neck Date: 2015-06-30 Impact factor: 3.147
Authors: Maria J Worsham; Josena K Stephen; Kang Mei Chen; Meredith Mahan; Vanessa Schweitzer; Shaleta Havard; George Divine Journal: Clin Cancer Res Date: 2013-03-26 Impact factor: 12.531
Authors: Dohun Pyeon; Michael A Newton; Paul F Lambert; Johan A den Boon; Srikumar Sengupta; Carmen J Marsit; Craig D Woodworth; Joseph P Connor; Thomas H Haugen; Elaine M Smith; Karl T Kelsey; Lubomir P Turek; Paul Ahlquist Journal: Cancer Res Date: 2007-05-15 Impact factor: 12.701
Authors: Robbert J C Slebos; Yajun Yi; Kim Ely; Jesse Carter; Amy Evjen; Xueqiong Zhang; Yu Shyr; Barbara M Murphy; Anthony J Cmelak; Brian B Burkey; James L Netterville; Shawn Levy; Wendell G Yarbrough; Christine H Chung Journal: Clin Cancer Res Date: 2006-02-01 Impact factor: 12.531
Authors: Daniela Russo; Francesco Merolla; Silvia Varricchio; Giovanni Salzano; Giovanni Zarrilli; Massimo Mascolo; Viviana Strazzullo; Rosa Maria Di Crescenzo; Angela Celetti; Gennaro Ilardi Journal: Biomed Rep Date: 2018-07-27
Authors: Gennaro Ilardi; Daniela Russo; Silvia Varricchio; Giovanni Salzano; Giovanni Dell'Aversana Orabona; Virginia Napolitano; Rosa Maria Di Crescenzo; Alessandra Borzillo; Francesco Martino; Francesco Merolla; Massimo Mascolo; Stefania Staibano Journal: Int J Mol Sci Date: 2018-03-16 Impact factor: 5.923